Thrivent Financial for Lutherans lessened its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 0.8% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 276,019 shares of the health services provider's stock after selling 2,092 shares during the period. Thrivent Financial for Lutherans owned 0.10% of The Cigna Group worth $95,624,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Edgestream Partners L.P. acquired a new position in The Cigna Group in the 1st quarter valued at about $1,763,000. UniSuper Management Pty Ltd boosted its stake in shares of The Cigna Group by 175.9% in the 1st quarter. UniSuper Management Pty Ltd now owns 6,780 shares of the health services provider's stock valued at $2,462,000 after buying an additional 4,323 shares during the period. Bessemer Group Inc. boosted its stake in shares of The Cigna Group by 23.3% in the 1st quarter. Bessemer Group Inc. now owns 28,097 shares of the health services provider's stock valued at $10,205,000 after buying an additional 5,308 shares during the period. Lake Street Advisors Group LLC boosted its stake in shares of The Cigna Group by 55.3% in the 1st quarter. Lake Street Advisors Group LLC now owns 3,629 shares of the health services provider's stock valued at $1,318,000 after buying an additional 1,292 shares during the period. Finally, Pitcairn Co. boosted its stake in shares of The Cigna Group by 11.2% in the 1st quarter. Pitcairn Co. now owns 8,021 shares of the health services provider's stock valued at $2,913,000 after buying an additional 809 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on CI. Jefferies Financial Group boosted their target price on The Cigna Group from $402.00 to $422.00 and gave the stock a "buy" rating in a research note on Tuesday, September 17th. JPMorgan Chase & Co. boosted their price objective on The Cigna Group from $435.00 to $438.00 and gave the company an "overweight" rating in a research note on Wednesday, August 21st. Piper Sandler reissued an "overweight" rating and issued a $394.00 target price (up previously from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. Cantor Fitzgerald reissued an "overweight" rating and issued a $400.00 target price on shares of The Cigna Group in a report on Wednesday, October 23rd. Finally, Royal Bank of Canada dropped their price objective on The Cigna Group from $384.00 to $377.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. One equities research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $394.64.
View Our Latest Analysis on CI
The Cigna Group Stock Up 0.3 %
Shares of CI stock traded up $0.88 during trading hours on Monday, reaching $322.40. The company had a trading volume of 1,194,358 shares, compared to its average volume of 1,543,959. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The Cigna Group has a twelve month low of $253.95 and a twelve month high of $370.83. The company has a market capitalization of $89.68 billion, a P/E ratio of 30.33, a price-to-earnings-growth ratio of 0.97 and a beta of 0.51. The stock's fifty day simple moving average is $338.88 and its 200 day simple moving average is $339.42.
The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating analysts' consensus estimates of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. During the same quarter last year, the firm earned $6.77 EPS. The Cigna Group's quarterly revenue was up 29.8% on a year-over-year basis. As a group, sell-side analysts expect that The Cigna Group will post 28.5 earnings per share for the current fiscal year.
The Cigna Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be issued a $1.40 dividend. This represents a $5.60 annualized dividend and a dividend yield of 1.74%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group's dividend payout ratio (DPR) is 52.83%.
The Cigna Group Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.